As Jivi launches, Bayer cuts 227 workers at U.S. plant that produces hemophilia treatment

4th October 2018 Uncategorised 0

Bayer’s recently approved weekly hemophilia treatment Jivi gives patients far more flexibility than those that need to be taken every day or so. It is proving to be less beneficial to more than 225 workers at Bayer’s hemophilia complex in California that produces the drug.

More: As Jivi launches, Bayer cuts 227 workers at U.S. plant that produces hemophilia treatment
Source: fierce